Results 231 to 240 of about 49,177 (260)

Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)

Expert Opinion on Therapeutic Targets, 2020
Elena Abati, Nereo Bresolin, Giacomo P Comi   +2 more
exaly  

Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2021
Pamela A Mccombe, Robert D Henderson, Shyuan T Ngo   +2 more
exaly  

Amyotrophic Lateral Sclerosis (ALS)

2008
openaire   +2 more sources

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2017
Michael J Strong, Laura H Goldstein, Paula M Mclaughlin   +2 more
exaly  

Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis

Nature, 2012
Claudia Fallini, Nicola Ticozzi, Peter C Sapp   +2 more
exaly  

Mutations of optineurin in amyotrophic lateral sclerosis

Nature, 2010
Hirofumi Maruyama, Hiroyuki Morino, Masaki Kamada   +2 more
exaly  

Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia

Neurology, 2010
Siddique T
exaly  

Amyotrophic Lateral Sclerosis (ALS)

2012
openaire   +1 more source

Amyotrophic Lateral Sclerosis (ALS)

2009
J.M. Bhatt, H. Mitsumoto
openaire   +1 more source

TRACE ELEMENT STUDIES IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Acta Pharmacologica et Toxicologica, 1986
J D, Mitchell, B W, East, I A, Harris, B, Pentland   +3 more
openaire   +2 more sources